KALOBIOS PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At- the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 3rd, 2013 • Kalobios Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 3rd, 2013 Company Industry JurisdictionKaloBios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: